Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • EpiBrass
    Member
    • Nov 2013
    • 16

    #1

    Methylation Study

    Hi,

    I'm a PhD student and currently working on building up a Methylome of a plant species. I have a plant line which has been inbred for 9 generations to ensure homozygosity. I would like to know whether it is more robust to perform the sequencing from a) tissue of several individuals from the same mother pooled together and sequenced several times, b) tissue of several individuals from the same mother indexed then pooled, c) tissue of several individuals sequenced once each separately or d) tissue from a single individual sequenced several times?

    * Using Illumina MiSeq *

    Cheers,

    Justin
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    Is the goal simply methylation profiling or do you also want to look at methylation differences (say between two related inbred strains with different phenotypes)?

    Comment

    • EpiBrass
      Member
      • Nov 2013
      • 16

      #3
      Originally posted by dpryan View Post
      Is the goal simply methylation profiling or do you also want to look at methylation differences (say between two related inbred strains with different phenotypes)?
      The aim of this is to develop a standard methylation profile with which I can later use as a reference to compare back to for methylation studies using different tissues at different time points under different growing conditions using the same inbred line. Thus deducing which genes/genome regions are at least in part regulated by methylation modulation in response to developmental or environmental stimuli.

      Comment

      • SNPsaurus
        Registered Vendor
        • May 2013
        • 525

        #4
        d) will tell you about technical variability, but I suspect that biological variation will dominate, so c) is the most robust (b is similar). If you know the variation, then you can assess if new samples fall within that variation or not. If you just do a) you will have the average, but you won't know if new samples differing from the average are examples of new methylation patterns or at the tail end of the distribution already seen.
        Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.com

        Comment

        • EpiBrass
          Member
          • Nov 2013
          • 16

          #5
          Originally posted by SNPsaurus View Post
          d) will tell you about technical variability, but I suspect that biological variation will dominate, so c) is the most robust (b is similar). If you know the variation, then you can assess if new samples fall within that variation or not. If you just do a) you will have the average, but you won't know if new samples differing from the average are examples of new methylation patterns or at the tail end of the distribution already seen.
          Thanks for that. Definitely a helpful clarification! I think what I'll do is a couple of technical reps (a) as well as assess biological variation (c) from a couple of individuals.

          Comment

          • dpryan
            Devon Ryan
            • Jul 2011
            • 3478

            #6
            I agree with SNPsaurus, either C or B (if the genome is quite small) will be your best bet. If the genome isn't smallish, you'll need technical replicates as well to get enough depth (if you're planning bisulfite-sequencing, keep in mind that the alignment rate is a bit lower than what you would otherwise get). Having said that, you'll be better served sequencing more samples at (relatively) low depth than just sequencing one pool or one sample at high depth (estimating variability and all that).

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              Today, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Today, 05:39 AM
            0 responses
            10 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, Yesterday, 09:56 AM
            0 responses
            12 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-09-2026, 11:14 AM
            0 responses
            26 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 09-29-2026, 09:51 AM
            0 responses
            77 views
            0 reactions
            Last Post SEQadmin2  
            Working...